Artificial intelligence + mobile medical = disease screening

In 2015, wearable devices flourished and the situation was in full swing. According to the "Report on Wearable Devices" issued by China Information and Communication Research Institute, the scale of China's wearable market has reached 12.58 billion yuan in 2015, with an annual growth rate of 471.8%. Experts from the China Institute of Information and Communications said that starting from 2016, the huge potential of some vertical areas will begin to be released, and the wearable market will officially enter the start-up period. It is expected that the wearable market will reach 20 billion yuan in 2016.

Artificial intelligence + mobile medical = disease screening

So what is the market feedback on wearables? What are the consumers most concerned about? According to the survey, the function is the main factor for consumers to purchase smart wearable devices, followed by price and appearance. However, at present, the functions of the smart wearable device are relatively simple and simple: the functions such as the step counting cannot solve the actual problem of the user, and most of the wearable devices are ruined, and the utility is not strong.

People not only have to ask: How far is the wearable device going from "concept" to "practical"?

At the same time that the concept of "Internet +" was put forward, Xiangma Technology (Shanghai) Co., Ltd. has been keenly aware that the era of "artificial intelligence +" is also opening. The battle of Li Shishi and AlphaGo in March this year is undoubtedly a milestone in the arrival of the "artificial intelligence +" era.

Artificial intelligence + mobile medical = disease screening

Xiangmao Technology is an innovative company dedicated to the development of mobile smart medical devices . Because of its long-term accumulation in artificial intelligence analysis algorithms, the company has been focusing on the development of mobile smart medical devices with automatic disease diagnosis, and is actively deployed in the blue ocean of “artificial intelligence + mobile medical ”.

The fast pace of life and the pressure of work have become the norm in today's society. The number of sub-healthy people is increasing day by day. Reports of white-collar death are not uncommon. Most of these people may have had the harbinger of shortness of breath and chest tightness, and these symptoms have laid a huge hidden danger for the occurrence of heart disease and the occurrence of arrhythmia. If you can launch a wearable device with automatic diagnosis of heart disease, it will undoubtedly have great practical value and market space.

Xiangma Technology has been thinking about how to use its advantages in artificial intelligence and automatic diagnostic algorithms to meet this huge market demand. At present, a wearable device with automatic arrhythmia intelligent diagnosis function is being developed to realize the "disease screening" function for heart diseases in sub-health populations.

I hope that in the near future, I can give a powerful answer to the impractical problem of current wearable devices: based on the technology of "artificial intelligence + mobile medical", the goal of "smart diagnosis, disease screening" can be achieved. The road from "concept" to "practical" for wearable devices is not far off!

ANSI Class 3

Ningbo Staneex Imp. & Exp. Co., Ltd. , https://www.staneex.com

Posted on